Palapattu GS - Search Results

1

MyProstateScore in men considering repeat biopsy: validation of a simple testing approach.

Tosoian JJ, Sessine MS, Trock BJ, Ross AE, Xie C, Zheng Y, Samora NL, Siddiqui J, Niknafs Y, Chopra Z, Tomlins S, Kunju LP, Palapattu GS, Morgan TM, Wei JT, Salami SS, Chinnaiyan AM. Tosoian JJ, et al. Among authors: palapattu gs. Prostate Cancer Prostatic Dis. 2023 Sep;26(3):563-567. doi: 10.1038/s41391-022-00633-3. Epub 2022 Dec 30. Prostate Cancer Prostatic Dis. 2023. PMID: 36585434 Free PMC article.

2

The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration.

Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter CR, Calhoun-Davis T, Li H, Palapattu GS, Pang S, Lin K, Huang J, Ivanov I, Li W, Suraneni MV, Tang DG. Qin J, et al. Among authors: palapattu gs. Cell Stem Cell. 2012 May 4;10(5):556-69. doi: 10.1016/j.stem.2012.03.009. Cell Stem Cell. 2012. PMID: 22560078 Free PMC article.

3

Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.

Kumar TR, Palapattu G, Wang P, Woodruff TK, Boime I, Byrne MC, Matzuk MM. Kumar TR, et al. Mol Endocrinol. 1999 Jun;13(6):851-65. doi: 10.1210/mend.13.6.0297. Mol Endocrinol. 1999. PMID: 10379885

4

Delivering enhanced testosterone replacement therapy through nanochannels.

Ferrati S, Nicolov E, Bansal S, Zabre E, Geninatti T, Ziemys A, Hudson L, Ferrari M, Goodall R, Khera M, Palapattu G, Grattoni A. Ferrati S, et al. Adv Healthc Mater. 2015 Feb 18;4(3):446-51. doi: 10.1002/adhm.201400348. Epub 2014 Oct 1. Adv Healthc Mater. 2015. PMID: 25274059 Free article.

5

Do prostate cancer patients at risk of pelvic lymph-node metastasis benefit from pelvic radiation?

Palapattu GS, Messing EM. Palapattu GS, et al. Nat Clin Pract Urol. 2006 May;3(5):258-9. doi: 10.1038/ncpuro0463. Nat Clin Pract Urol. 2006. PMID: 16691238 No abstract available.

6

Acute bilateral renal cortical necrosis as a cause of postoperative renal failure.

Palapattu GS, Barbaric Z, Rajfer J. Palapattu GS, et al. Urology. 2001 Aug;58(2):281. doi: 10.1016/s0090-4295(01)01146-3. Urology. 2001. PMID: 11489723

7

Monoclonal antibody therapy for genitourinary oncology: promise for the future.

Palapattu GS, Reiter RE. Palapattu GS, et al. J Urol. 2002 Dec;168(6):2615-23. doi: 10.1016/S0022-5347(05)64230-9. J Urol. 2002. PMID: 12441996 Review.

8

Collecting system invasion in renal cell carcinoma: impact on prognosis and future staging strategies.

Palapattu GS, Pantuck AJ, Dorey F, Said JW, Figlin RA, Belldegrun AS. Palapattu GS, et al. J Urol. 2003 Sep;170(3):768-72; discussion 772. doi: 10.1097/01.ju.0000082580.13597.a2. J Urol. 2003. PMID: 12913694

9

The association of selected pathological features with prostate cancer in a single-needle biopsy accession.

Hu JC, Palapattu GS, Kattan MW, Scardino PT, Wheeler TM. Hu JC, et al. Among authors: palapattu gs. Hum Pathol. 1998 Dec;29(12):1536-8. doi: 10.1016/s0046-8177(98)90027-2. Hum Pathol. 1998. PMID: 9865844

10

Resolution of the chronic pelvic pain syndrome after renal transplantation.

Palapattu GS, Shoskes DA. Palapattu GS, et al. J Urol. 2000 Jul;164(1):127. J Urol. 2000. PMID: 10840443 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page